ZFIC Alliance

The Zhongguancun First-in-Class Innovative Drug Global Strategic Development Alliance (ZFIC Alliance) is a prominent Chinese industry organization dedicated to accelerating the development and global commercialization of "first-in-class" (FIC) therapeutics. Formed by a coalition of leading biopharmaceutical companies, research institutes, and investment groups, the alliance aims to address critical challenges in financing, regulatory navigation, and international market entry for Chinese innovators. ZFIC facilitates high-level strategic collaborations and hosts major industry events, such as the China FIC Innovation and Collaboration Summit held alongside the J.P. Morgan Healthcare Conference. Its member network includes over 40 entities, including Hotgen Biotech, Kelun-Biotech, and Biocytogen, focusing on cutting-edge modalities such as ADCs, RNAi, and gene therapies. By bridging the gap between domestic innovation and global resources, the ZFIC Alliance plays a pivotal role in transitioning China's pharmaceutical sector from "fast-follow" strategies to foundational innovation.